Adaptive Reprogramming of De Novo Pyrimidine Synthesis Is a Metabolic Vulnerability in Triple-Negative Breast Cancer
Kristin K Brown, Jessica B Spinelli, John M Asara, Alex Toker
Cancer Discovery | AMER ASSOC CANCER RESEARCH | Published : 2017
Awarded by NATIONAL CANCER INSTITUTE
This work was supported by the Ludwig Center at Harvard.